Improving access to genetic testing for cancer survivors in underserved communities
Addressing Genomic Disparities in Cancer Survivors
['FUNDING_R01'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-11021051
This study is looking at how to make genetic testing for hereditary cancer easier to access for Black cancer survivors by using new digital tools, so they can get the support they need without facing barriers.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-11021051 on ClinicalTrials.gov |
What this research studies
This research aims to address the significant racial disparities in access to genetic testing for hereditary cancer among survivors, particularly focusing on Black populations. It will explore new models of genome-based care that utilize digital interventions to improve access to genetic counseling and testing, thereby reducing barriers faced by underserved minorities. The study will involve a randomized controlled trial to evaluate the effectiveness of these innovative approaches in enhancing the referral and testing rates for genetic counseling. By engaging with community needs, the research seeks to create a more equitable healthcare system for cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black cancer survivors who have not received genetic testing and are at high risk for hereditary cancer.
Not a fit: Patients who have already undergone genetic testing or do not identify as part of the targeted racial groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to genetic testing for cancer survivors, ultimately enhancing treatment options and preventive measures for both patients and their families.
How similar studies have performed: Other research has shown promise in using digital interventions to improve access to healthcare services, suggesting that this approach could be effective in addressing genomic disparities.
Where this research is happening
Newark, UNITED STATES
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KINNEY, ANITA Y. — RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- Study coordinator: KINNEY, ANITA Y.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, anti-cancer therapy